[1] |
LIU Qian, HU Jing, LI Bo, YANG Xiaojing.
Jinghuaweikang capsules combined with quadruple therapy in the treatment of Helicobacter pylori associated gastritis: a systematic evaluation and meta-analysis
[J]. Chinese Journal of Pharmacovigilance, 2023, 20(9): 1039-1045.
|
[2] |
CHEN Jie, QIN Kan.
Evaluation of individualized parenteral nutrition delivery
[J]. Chinese Journal of Pharmacovigilance, 2023, 20(7): 812-816.
|
[3] |
LI Tan, ZHANG Yang, ZHANG Wangde, WANG Yun.
Efficacy and safety of different analgesia drugs in the treatment of lower extremity ischemic pain
[J]. Chinese Journal of Pharmacovigilance, 2023, 20(6): 680-683.
|
[4] |
SU Xinxin, LYU Jian, XIE Yanming.
Efficacy and safety of Toutongning capsules in the treatment of chronic headache: a Meta-analysis
[J]. Chinese Journal of Pharmacovigilance, 2023, 20(4): 433-440.
|
[5] |
LI Qianqian, XIA Yan, HOU Tiantian, WANG Chao, SHI Xixi, MA Xuemei, LIU Ziyang, ZHANG Yingli, WU Xiaobing, WANG Sanlong, LIU Guoqing, GENG Xingchao.
Nonclinical evaluation of safety of gene therapy drug AAV5 lipoprotein lipase variant (GC304) in the nervous system
[J]. Chinese Journal of Pharmacovigilance, 2023, 20(1): 34-39.
|
[6] |
WANG Huiqiang, YAN Haiyan, LI Xingqiong, YANG Jie, LI Yuhuan.
Efficacy of lycorine thioester hydrochloride against coxsackievirus A16 in vivo
[J]. Chinese Journal of Pharmacovigilance, 2023, 20(1): 79-84.
|
[7] |
HUANG Ying, HOU Tiantian, QIN Chao, HUO Yan, WANG Sanlong, WEN Hairuo, GENG Xingchao.
Nonclinical research on CAR-T cell products: main concerns and key issues
[J]. Chinese Journal of Pharmacovigilance, 2022, 19(8): 813-816.
|
[8] |
WANG Chen, GAO Jie, LIU Ying, CHEN Tao, XU Mingzhe.
Physiological pharmacokinetic model based evaluation of the efficacy of penicillamine tablets against Wilson's disease
[J]. Chinese Journal of Pharmacovigilance, 2022, 19(7): 708-711.
|
[9] |
WANG Chen, GAO Jie, ZHANG Dousheng, XU Mingzhe.
Evaluation on the efficacy of cefazolin sodium based on physiological pharmacokinetic models
[J]. Chinese Journal of Pharmacovigilance, 2022, 19(7): 717-720.
|
[10] |
ZHANG Shuai, GENG Yue, WAN Liyan, JI Liwei.
Efficacy and safety of insulin degludec vs other long-acting basal insulin analogues in the treatment of type 1 diabetes
[J]. Chinese Journal of Pharmacovigilance, 2022, 19(12): 1358-1361.
|
[11] |
YIN Xiang, WANG Xi, SHI Chunhui, WANG Zongwei, WANG Lin, YAO Shangchen, XU Mingzhe.
Feasibility study on grape seed proanthocyanidins as a new ophthalmic antibacterial agent
[J]. Chinese Journal of Pharmacovigilance, 2022, 19(11): 1174-1180.
|
[12] |
LI Guowei, LI Likang, LIU Yingxin, WANG Ruoting, WU Darong.
Common problems related to P-value in observational pharmacoepidemiological studies
[J]. Chinese Journal of Pharmacovigilance, 2022, 19(1): 23-26.
|
[13] |
WANG Chen, XU Mingzhe.
Efficacy of Oral Dosage Forms of Clindamycin Palmitate Hydrochloride
[J]. Chinese Journal of Pharmacovigilance, 2021, 18(7): 606-610.
|
[14] |
CHENG Xialong, ZHANG Xulai, WU Xiaoping, DAI Biao, WANG Anzhen, YAN Fanfan.
Aripiprazole's Effect on Metabolism in Patients with Behavioral and Psychological Symptoms of Dementia and Correlations between Clinical Efficacy and Blood Concentration
[J]. Chinese Journal of Pharmacovigilance, 2021, 18(7): 641-644.
|
[15] |
ZHANG Bing, LYU Jintao, ZHANG Xiaomeng, LIN Zhijian.
Traditional Chinese Medicine Property-Based Understanding of Toxicity, Efficacy and Pharmaco-vigilance
[J]. Chinese Journal of Pharmacovigilance, 2021, 18(5): 411-415.
|